XML 66 R46.htm IDEA: XBRL DOCUMENT v3.25.1

Stock Compensation Plans (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Assumptions Used

The following table summarizes the assumptions used in estimating the fair value of each stock option granted along with the weighted-average fair value of the stock options granted.

 Schedule of Assumptions Used

								Assumptions
Grant Date		Plan		Weighted- Average Fair Value of Each Option				Expected Dividend Yield (1)				Underlying stock FMV				Weighted- Average Volatility				Weighted- Average Risk-Free Interest Rate				Weighted- Average Expected Life (years)
December 26, 2024		All Plans		$	3.01				5	%		$	11.87				38.41	%			4.38	%			5.31
December 6, 2024		All Plans		$	3.17				5	%		$	13.08				38.17	%			4.00	%			5.12
January 12, 2024		All Plans		$	2.01				5	%		$	8.35				37.51	%			3.81	%			5.31
January 8, 2024		All Plans		$	2.16				5	%		$	8.93				37.50	%			3.93	%			5.31
December 1, 2023		All Plans		$	1.88				5	%		$	7.99				36.76	%			4.14	%			4.90
January 30, 2023		All Plans		$	1.65				5	%		$	7.10				36.73	%			3.64	%			5.31
January 18, 2023		All Plans		$	1.70				5	%		$	7.37				36.79	%			3.40	%			5.31

⁽¹⁾ Stock dividend

Schedule of Activity of Stock Option Plans

The activity of the stock option plans is summarized as follows:

 Schedule of Activity of Stock Option Plans

		Number of Class A Shares				Weighted Average Exercise Price (2)				Number of Class C Shares				Weighted Average Exercise Price (2)
Outstanding at January 1, 2023			976,605			$	4.33				1,157,203			$	5.04
Adjustment for the effect of stock dividends			38,266								57,859
Granted			106,500								305,000
Exercised			(286,965	)							-
Cancelled			(836	)							-
Outstanding at December 31, 2023			833,570			$	4.91				1,520,062			$	5.57
Adjustment for the effect of stock dividends			38,724								76,005
Granted			59,200								330,000
Exercised			(267,491	)							(201,667	)
Cancelled			(17,409	)							-
Outstanding at December 31, 2024			646,594			$	5.93				1,724,400			$	7.23
Exercisable at end of year			599,769			$	5.42				1,394,400			$	5.82
Available options for future grant			79,281								146,238
Weighted average contractual term of options outstanding at December 31, 2024			5.55 years								6.71 years
Weighted average contractual term of options exercisable at December 31, 2024			5.36 years								6.05 years
Aggregated intrinsic value of options outstanding at December 31, 2024 (1)		$	3,944,715							$	8,269,398
Aggregated intrinsic value of options exercisable at December 31, 2024 (1)		$	3,962,435							$	8,652,316

(1) The Company used a stock price of $12.03 as of December 31, 2024 to derive intrinsic value.

(2) Adjusted for the effect of annual stock dividends.

Schedule of Activity Restricted Stock Units

The activity of the RSUs is summarized as follows:

 Schedule of Activity Restricted Stock Units

		Number of Class A Shares				Weighted Average Grant Date Fair Value
Non-vested at January 1, 2023			1,620			$	6.48
Granted			1,840
Vested			(1,215	)
Non-vested at December 31, 2023			2,245			$	7.72
Granted			12,353
Vested			(1,785	)
Non-vested at December 31, 2024			12,813			$	12.90
Available RSUs for future grant			4,187

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (k)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

+ Details

Name:	us-gaap_ScheduleOfAssumptionsUsedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration